agilon health, inc.

Thank you all for joining. I'd like to welcome you all to the Agilon Health first quarter 2023 earnings conference call. My name is Brica and I will be operator for today's call. At this time all participants are in a listen only mode and after the speaker's remarks you will have an opportunity to ask a question. To do so please press star then one on your telephone keypad. If you change your mind please press star then two. And for operator assistance at any point, it's the star zero key. Thank you. I would now like to turn the call over to Matthew Gilmore, Vice President of Investor Relations. So, Matthew, you may begin.

Thank you, operator. Good afternoon and welcome to the call. With me is our CEO, Steve Sell, and our CFO, Tim Bentley. Following prepared remarks from Steve and Tim, we will conduct a Q&A session. I'd like to remind you that our remarks and responses to questions may include forward-looking statements. Actual results may differ materially from those stated or implied by forward-looking statements due to risks and uncertainties associated with our business. These risks and uncertainties are discussed in our SEC filings. Please note that we assume no obligation to update any forward-looking statements. Additionally, certain financial measures we will discuss in this call are non-GAAP financial measures. We believe that providing these measures helps investors gain a better and more complete understanding of our financial results and is consistent with how management views our financial results. A reconciliation of these non-GAAP financial measures to the most comparable GAAP measure is available in the earnings press release and Form 8K file with the SEC. You'll note from the press release that we've changed the presentation for certain non-GAAP financial measures. Before Steve's remarks, Tim will review these changes. So with that, let me turn the call over to Tim.

Thanks, Matt. Before we give our prepared remarks, I want to review the revised presentation for adjusted EBITDA and gross profit. As you know, we've always been committed to transparency and provide a lot of details on our performance. We recently made the determination that we should include geography entry costs within adjusted EBITDA to conform to the SEC's recent guidance on non-GAAP financial measures. We will continue to provide transparency around these investments on a go-forward basis. For clarity, we want to define gross profit and adjusted EBITDA before we begin the call. We've replaced network contribution with GAAP gross profit. Gross profit is total revenues, less medical services expense, and other medical expenses, which include a portion of geography entry costs. Adjusted EBITDA now includes total geography entry costs, which was $12 million in the quarter. This includes the portion of geography entry costs within our other medical expenses and geography entry costs within our G&A expenses. With that, I'll turn the call over to Steve.